|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: 3 DIMENSIONAL PHARMACEUTICALS INC, 10-Q, 2000-11-08 |
Next: AMVESCAP PLC/LONDON/, 6-K, 2000-11-08 |
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> SEP-30-2000
<CASH> 121,192
<SECURITIES> 0
<RECEIVABLES> 542
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 123,544
<PP&E> 11,060
<DEPRECIATION> (6,294)
<TOTAL-ASSETS> 129,460
<CURRENT-LIABILITIES> 26,649
<BONDS> 0
0
0
<COMMON> 21
<OTHER-SE> 101,112
<TOTAL-LIABILITY-AND-EQUITY> 129,460
<SALES> 0
<TOTAL-REVENUES> 8,609
<CGS> 0
<TOTAL-COSTS> 15,227
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 565
<INCOME-PRETAX> (5,490)
<INCOME-TAX> 320
<INCOME-CONTINUING> (5,810)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (5,810)
<EPS-BASIC> (1.33)
<EPS-DILUTED> (1.33)
</TABLE>
|
|